Sangamo Therapeutics' Unattributed VC - III Round

Sangamo Therapeutics raised a round of funding on January 12, 2001. Investors include AAC Capital Partners.

Sangamo Therapeuticsm aka Sangamo BioSciences, of Richmond, CA, is focused on the research and development of novel transcription factors for the regulation of gene expression. The company's most adva…

Articles about Sangamo Therapeutics' Unattributed VC - III Round: